How many institutions held SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q4 2019?

70 institutional investors reported SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q4 2019. Use the holders table for investor-level position and value details.

Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Q: What does CUSIP 87184Q107 represent in this 13F holders report?

CUSIP 87184Q107 is the security identifier for SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 87184Q107

Q4 2019 13F Holders as of 31 Dec 2019

Security type / class: Equity / Common Stock, $0.001 par value
Total 13F shares: 42,159,417
Total 13F value: $290,644,730
Share change: -916,708
SEC-reported price per share: $6.91
Number of holders: 70
Value change: -$8,983,413
Number of buys: 48
Number of sells: 22
Shares outstanding: 27,995,500

Security key

87184Q107

Report period

Q4 2019

Institutions

Top holders

SYRS full security history Ownership snapshot Full 13F holder table Syros Pharmaceuticals, Inc. SEC filings Syros Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

30 Sep 2019

13F Lead comparable stake: 22% Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 22%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Comparable ownership Top 5

FMR LLC 22%

Amova Asset Management Americas, ... 17%

Sumitomo Mitsui Trust Group, Inc. 17%

Redmile Group, LLC 14%

ARCH Venture Management, LLC 14%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	22%	$63,681,000 6,134,961 shares	—	30 Sep 2019
Amova Asset Management Americas, Inc.	13F Company 13F	17%	$48,099,000 4,633,773 shares	—	30 Sep 2019
Sumitomo Mitsui Trust Group, Inc.	13F Company 13F	17%	$48,099,000 4,633,773 shares	—	30 Sep 2019
Redmile Group, LLC	13F Company 13F	14%	$40,365,000 3,888,752 shares	—	30 Sep 2019
ARCH Venture Management, LLC	13F Company 13F	14%	$40,015,000 3,855,051 shares	—	30 Sep 2019
ARK Investment Management LLC	13F Company 13F	14%	$39,804,000 3,834,728 shares	—	30 Sep 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

42,159,417

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 value	Q4 2019 value	Value change	Value Chg %